Awardee OrganizationVIRGINIA COMMONWEALTH UNIVERSITY
Description
Abstract Text
While the existence of a familial aggregation of seizures and
epileptic syndromes has been well established, a need for more
definitive studies that address the nature of the factors
responsible for the observed pattern of familial aggregation
clearly exists. Twin and twin kinship studies provide extremely
powerful tools for measuring the importance of genetic influences
on a trait, as well as, differentiating between alternative
explanations for observed patterns of inheritance. The objectives
of the proposed study are to determine the degree to which genetic
factors play a significant role in the etiology of febrile seizures
and epilepsy and to ascertain the extent to which maternal effects
contribute to the predisposition to these disorders utilizing
information collected from affected and control twin pairs and twin
kinships who were ascertained through the Virginia or Norwegian
Twin Registries. These population-based panels will provide the
largest sample of affected twins that has been studied to date.
A preliminary survey of the health history information available
on registry members has indicated that there are currently 210 twin
pairs reporting epilepsy or febrile seizures available for study
in Virginia along with 320 pairs in Norway. In addition, 403
kinships in which febrile seizure is reported in the offspring of
twins are included in the Norwegian panel, along with, an estimated
160 in the Virginia group. Both twin registries will be resurveyed
for the occurrence of seizure disorders in twins using a
questionnaire specifically developed or this purpose. Classical
twin studies will be used to determine the role which genetic
factors play in the etiology of seizure disorders. Case and
control twin pairs will be evaluated to examine the effects of
demographic variables on the incidence of the traits under study.
Finally, twin kinship studies will be used to detect the influence
of maternal effects on the occurrence of seizure disorders.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
105300446
UEI
MLQFL4JSSAA9
Project Start Date
01-June-1998
Project End Date
31-December-1999
Budget Start Date
Budget End Date
Project Funding Information for 1998
Total Funding
Direct Costs
Indirect Costs
Sub Projects
No Sub Projects information available for 5P50NS025630-10 0004
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50NS025630-10 0004
Patents
No Patents information available for 5P50NS025630-10 0004
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50NS025630-10 0004
Clinical Studies
No Clinical Studies information available for 5P50NS025630-10 0004
News and More
Related News Releases
No news release information available for 5P50NS025630-10 0004
History
No Historical information available for 5P50NS025630-10 0004
Similar Projects
No Similar Projects information available for 5P50NS025630-10 0004